Psychedelics trigger psychedelic experiences

The argument

Proponents of this view begin from a straightforward pharmacological claim: the major psychedelic drugs, among them LSD, DMT, mescaline and psilocybin, share a common mode of action, acting primarily on the serotonin receptors of the brain. A receptor is the site at which a neurotransmitter binds and exerts its effect, so a drug that occupies or stimulates serotonin receptors is not introducing a wholly novel signal but intervening in a signalling system the brain already uses continuously. That matters because of what serotonin does. On this account serotonin is not a narrow, single-purpose chemical but an important neurotransmitter implicated across many areas of brain function, including cognition, learning and memory, and it is most commonly associated with rewarding feelings of happiness and contentment. A substance that perturbs serotonin signalling is therefore perturbing the very processes that assemble experience: how information is taken in and interpreted, how it is laid down and recalled, and how it is emotionally coloured. The inference follows from putting those two points together. If perception and conscious experience are constructed by neurochemical processes, and if psychedelics intervene directly in one of the neurotransmitter systems those processes depend on, then altered perception is the expected result rather than an incidental side effect. This is why, proponents argue, the reported effects are so various: influencing the complex neurochemistry of serotonin can trigger a myriad of changes to perception and consciousness, ranging from trance-like states through flashbacks to psychotic episodes. The breadth of that range is itself treated as evidence for the mechanism, since a chemical touching cognition, memory and mood at once would be expected to produce disturbances at several different levels of experience rather than one signature effect. Hallucinogens, on this view, alter perception and cause hallucinations precisely because they act at the place where perception is made.

Premises

Counter-arguments

A precision objection notes that classic psychedelics act specifically on the 5-HT2A serotonin receptor, not on serotonin receptors in general, so the broad-brush 'they act on serotonin' account obscures the actual mechanism. Serotonin's popular association with 'happiness and contentment' is itself an oversimplification, and disrupting one receptor subtype does not simply 'reshape' all of the brain's neurochemistry. Critics add that classic serotonergic psychedelics rarely produce true hallucinations — perceiving things that are wholly absent — but instead distort existing perception; this is why the label 'hallucinogen' is itself contested. Describing them as reliably causing 'hallucinations' and 'psychotic episodes' overstates the typical effect.

Rejecting the premises

[Rejecting P1] Psychedelics act specifically on the 5-HT2A serotonin receptor, not serotonin receptors generally; the broad account obscures the mechanism. [Rejecting P2] Serotonin's role in 'happiness and contentment' is itself an oversimplification, and disrupting one receptor subtype does not simply 'reshape' all the brain's neurochemistry. [Rejecting P3] Classic psychedelics rarely produce true hallucinations (perceiving things wholly absent); they more often distort existing perception, so 'cause hallucinations' and 'psychotic episodes' overstate the typical effect.